Managing Graves' orbitopathy

Int Ophthalmol Clin. 1998 Winter;38(1):103-15. doi: 10.1097/00004397-199803810-00009.
No abstract available

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Glucocorticoids / therapeutic use
  • Graves Disease / diagnosis
  • Graves Disease / etiology
  • Graves Disease / therapy*
  • Humans
  • Hyperparathyroidism / complications
  • Hyperparathyroidism / therapy
  • Immunosuppressive Agents / therapeutic use
  • Optic Neuritis / diagnosis
  • Optic Neuritis / etiology
  • Optic Neuritis / therapy
  • Orbital Diseases / diagnosis
  • Orbital Diseases / etiology
  • Orbital Diseases / therapy*
  • Radiotherapy, Adjuvant
  • Strabismus / diagnosis
  • Strabismus / etiology
  • Strabismus / therapy
  • Vision Disorders / diagnosis
  • Vision Disorders / etiology
  • Vision Disorders / therapy

Substances

  • Glucocorticoids
  • Immunosuppressive Agents